Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.
about
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndromeHigh versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndromeHigh versus low positive end-expiratory pressures (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndromePharmacologic therapies for adults with acute lung injury and acute respiratory distress syndromeEconomic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilationRelevant Outcomes in Pediatric Acute Respiratory Distress Syndrome StudiesStatins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysisEffect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical TrialPlasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.Right and left heart failure in severe H1N1 influenza A infectionMortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial.Weaning and extubation readiness in pediatric patientsA phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryAntithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study.A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.Bayesian design using adult data to augment pediatric trials.Control of hyperglycaemia in paediatric intensive care (CHiP): study protocolSaline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial.Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injuryPlasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury.Outcomes for Children Receiving Noninvasive Ventilation as the First-Line Mode of Mechanical Ventilation at Intensive Care Admission: A Propensity Score-Matched Cohort StudyGoal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation AssaysAlcohol screening scores and 90-day outcomes in patients with acute lung injuryFurosemide and albumin for diuresis of edema (FADE): a study protocol for a randomized controlled trial.Low plasma selenium concentrations in critically ill children: the interaction effect between inflammation and selenium deficiencyEffect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.Temporal trends of postinjury multiple-organ failure: still resource intensive, morbid, and lethal.Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation.4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumoniaEffect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial.Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammationA principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysisThe association between BMI and plasma cytokine levels in patients with acute lung injury.APCAP--activated protein C in acute pancreatitis: a double-blind randomized human pilot trial.Plasma Adiponectin, clinical factors, and patient outcomes during the acute respiratory distress syndrome.Preventing ARDS: progress, promise, and pitfallsTumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patients.Steroids for acute respiratory distress syndrome?Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia.
P2860
Q24201112-C2A618B6-94DA-47DC-BBAC-920FDF4B0D72Q24202074-1D237B5B-38F2-4A6A-A472-21FA77517D9CQ24235011-0272DDFD-8520-48E2-9ED7-063850655422Q24246217-9A3F5669-26FB-40A6-9CD9-F27F3DD7C960Q24652346-C3EB4767-25B7-479C-A565-22A408A57DE0Q26744504-A1D09358-A193-4B70-8E23-9707DAE20BB5Q26746082-A9805A05-D707-4792-842E-101645B56848Q27347527-09692CD9-A0DD-4519-AF97-CDBC8E2F8FEDQ30360456-5C5E3EF0-D778-4D98-B916-C5276715EC5EQ30360992-B5FECEFD-CA67-4375-ACF5-725189CDD5C0Q30389882-4D0D4959-DD34-4294-B13A-323BBD41C995Q30423714-D950FFAD-185C-4BAF-9ABE-91313DC93F1CQ30436539-190BC03D-39A4-4033-9D05-1CC860007650Q30501707-5A3490C1-F684-4D54-9AD9-0036129B01BBQ30839302-7575A123-5806-4EFB-9DE8-0D825F41644CQ33236613-6DF0EC88-673A-41B3-86CF-E7554D9AD4B1Q33492143-F56D57EF-38BA-422E-968A-B962404B30ECQ33529877-D8F265FE-A5EA-4631-AEB1-0170D98780FBQ33560840-EFAFA166-6967-460E-BB9F-10A9B4E1105EQ33595107-8DDF2E77-7A24-49BF-80FB-EAEB2A4CA7A9Q33685205-620D29FC-4F16-4701-8E56-EBB4553BE420Q33688101-EB80177B-D7F0-4C30-A3B3-375E67776FDDQ33689210-F0E988BC-A419-4C5C-A5F4-8806CE4362DBQ33723496-3775BD5B-F090-4F65-A72B-92172179CFE6Q33761098-CE1FE03E-8B91-4674-8A8A-2D1B58780E67Q33821931-9E9356F0-19B0-413F-AE39-12A9A42DB05BQ33919074-12F3F9C3-C8A9-4BB7-980A-85BE516672D7Q33974781-F860B89B-DE43-46A8-ADED-FFF50C98F748Q33998931-0DBA3A98-5879-4825-A0D2-DEABE45E2C3BQ34022566-BF86409D-0D44-4A27-81E8-1747DE34669AQ34049582-7BF8DB95-F675-4675-A45E-B171223AD0DDQ34073788-285F19EC-6DAC-42F1-B562-3A7CBAD8D613Q34115729-7EBA3BC1-94A0-434F-A459-8A071FCD53D2Q34130717-F36EB106-BC64-479D-A0CC-8CBB181796B9Q34153283-02335120-2694-4F8A-AD8B-AFAB478E225FQ34258758-16D36859-DD0C-4814-ABC9-525B42EAAACFQ34299807-E7B09BBA-3077-4679-8A7C-1F10806AE814Q34322962-71FEA0EE-921D-42CD-A528-A0C441681CAEQ34451061-C0D1F58B-9F01-46F8-B596-836CEC107E15Q34510887-7984CB8E-0B30-4FCA-81FC-CB7D0234E36F
P2860
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Statistical evaluation of vent ...... respiratory distress syndrome.
@en
Statistical evaluation of vent ...... respiratory distress syndrome.
@nl
type
label
Statistical evaluation of vent ...... respiratory distress syndrome.
@en
Statistical evaluation of vent ...... respiratory distress syndrome.
@nl
prefLabel
Statistical evaluation of vent ...... respiratory distress syndrome.
@en
Statistical evaluation of vent ...... respiratory distress syndrome.
@nl
P2093
P921
P1476
Statistical evaluation of vent ...... respiratory distress syndrome.
@en
P2093
ARDS Network
David A Schoenfeld
Gordon R Bernard
P304
P356
10.1097/00003246-200208000-00016
P407
P577
2002-08-01T00:00:00Z